共 8 条
- [1] Transplantation of a human ovarian cystadnocarcinoma into severe combined immunodeficient(SCID) mice-formation of metastases without significant alteration of the tumour cell phenotype. Schumscher U,Adam E,Horny HP,et al. Int J Path . 1996
- [2] High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. Shpitz B,Chambers CA,Singhal AB,et al. Journal of Immunological Methods . 1994
- [3] Epidemiology and risk assessment for ovarian cancer. Daly M,Obrams I. Seminars in Oncology . 1998
- [4] Humoral immunity in SCID mice reconstituted with cells from immunoglobulin-deficient or normal humans. Smith CIE,Abedi MR,Islam KB,et al. Immunological Reviews . 1991
- [5] Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution. Hesselton RM,Koup RA,Cromwell MA,et al. The Journal of Infectious Diseases . 1993
- [6] Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. Sandhu J,Shpitz B,Gallinger S,et al. J Immunol . 1994
- [7] The human immune system in hu-PBL-SCID mice. Tary-Lehmann M,Saxon A,Lehmann PV. Immunology Today . 1995
- [8] The development of a novel immunotherapy model of human ovarian cancer in human PBL-severe combined immunodeficient(SCID) mice. Walker W,Gallagher G. Clinical and Experimental Immunology . 1995